Search PubMed⌕ Search

Biomedical subjects

R Corona

Publications and source records attributed to R Corona.

59 records · Page 4Linked to original sources
PubMedDate not supplied

[Cerebral phospholipids and Parkinson's disease: cross-over double-blind study versus placebo].

Authors refer in this study their clinical experience with brain cortex phospholipids (BC-PL) in patients affected by Parkinson's disease and treated with L-DOPA plus IDD. It's plain from results elaborated through statistical examinations a positive influence more on motor timing performances (screw-test, gait-test, peg-board test) than each item of Webster rating scale. Moreover getting in connection high nervous functions with motor activity, authors suppose BC-PL have a primary and direct action on cortical cholinergic structures correlated with attention, learning and memory and consequently a secondary action on motor performances.

Animals↗
PubMedDate not supplied

[Double-blind study of the effects of amitriptyline and of a combination of amitriptyline and lithium on patients with chronic primary headache].

The Authors report their experience in a "double-blind" study in patients affected by chronic primitive headache. 30 patients have been examined: the first one were prescribed amitriptyline, the other one amitriptyline plus lithium association for 30 days. The study pointed out treatments have been effective in reducing frequency, duration and intensity of headache, even though the amitriptyline is more effective in the prophylaxis of chronic headache, whilst amitriptyline plus lithium association seems to be more effective in subacute headache.

Amitriptyline↗
PubMedDate not supplied

[Double-blind study of tiapride and placebo in patients with subcontinuous essential headache].

25 patients with subcontinual primary headache were treated with Tiapride an Placebo in a controlled double-blind study. The duration of trial was 13 weeks. Blood samples were taken to value PRL in 10 patients and in 10 normal subjects. During the pharmacological trial no side-effects appeared. Authors refer results elaborated through statistical examinations. Tiapride is useful to reduce the frequency of the attacks (in 65% of the patients) with percentage of improvement statistically significant in comparison with placebo. Headache index appears influenced although in non statistically significant way.

Adult↗